CSI Market
Sign In | Register

Tarsus Pharmaceuticals Inc (TARS) Annual Balance Sheets

Annual · GAAP · USD millions
Access TARS quarterly Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Tarsus Pharmaceuticals Inc.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent0.00
Marketable Securities, Current SH233.63
Cash & Short-term Investments233.00
Accounts receivable85.06
Other Receivables, Net, Current2.05
Inventories4.37
Other Current Assets184.20
Prepaid Expense, Current AS13.47
Total Current Assets522.78
Equipment/Property/Plant Net11.67
Intangible Assets7.37
Long-term investments3.87
Other Assets, Noncurrent20.35
Restricted Cash Current0.56
Cash And Cash Equivalents Fair Value Disclosure183.64
Operating Lease Right Of Use Asset10.08
Total Assets562.16
Liabilities
Accounts Payable, Current AC16.39
Employee-related Liabilities, Current AC17.78
Other Liabilities, Current101.53
Total Current Liabilities135.70
Long-term debt72.44
Total Long-term Debt72.44
Other liabilities, Noncurrent10.60
Total Liabilities218.73
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock769.67
Retained Earnings / Accumulated Deficit-426.63
Other Equity0.38
Common Stockholder's Equity343.43
Total Stockholder's Equity343.43
Liabilities & Stockholder's Equity562.16
4 historic quarters locked

Sign in to unlock the full Tarsus Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Tarsus Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 23, 2026
  • Source: tars-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001819790-26-000019

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.